Minerva Neurosciences, Inc.
NERV
$4.58
$0.6616.84%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -394.35M | -415.07M | -293.42M | -14.03M | 11.23M |
| Total Depreciation and Amortization | 2.80K | 4.20K | 5.60K | 5.60K | 5.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 4.30K |
| Total Other Non-Cash Items | 372.20M | 398.18M | 280.54M | 1.12M | -25.43M |
| Change in Net Operating Assets | -4.02M | 2.03M | -632.30K | -1.29M | -1.45M |
| Cash from Operations | -26.17M | -14.87M | -13.51M | -14.20M | -15.63M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -50.13M | -45.29M | -- | -- | -- |
| Cash from Investing | -50.13M | -45.29M | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 91.70M | 81.20M | 80.00M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.00M | -5.67M | -5.55M | -45.20K | -- |
| Cash from Financing | 85.70M | 75.53M | 74.45M | -45.20K | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.40M | 15.37M | 60.94M | -14.24M | -15.63M |